相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders
Kazuaki Chayama et al.
HEPATOLOGY (2012)
Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan
Hiromitsu Kumada et al.
JOURNAL OF HEPATOLOGY (2012)
Genome-wide Association Study Identifies Variations in 6p21.3 Associated With Nevirapine-Induced Rash
Soranun Chantarangsu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
Masatoshi Kudo et al.
DIGESTIVE DISEASES (2011)
Targeted Therapies for Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2011)
HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy
C. Nelson Hayes et al.
GUT (2011)
Hepatitis C Pharmacogenetics: State of the Art in 2010
Nezam H. Afdhal et al.
HEPATOLOGY (2011)
Influence of ITPA Polymorphisms on Decreases of Hemoglobin During Treatment with Pegylated Interferon, Ribavirin, and Telaprevir
Fumitaka Suzuki et al.
HEPATOLOGY (2011)
Strong Influence of Human Leukocyte Antigen (HLA)-DP Gene Variants on Development of Persistent Chronic Hepatitis B Virus Carriers in the Han Chinese Population
Xiuchan Guo et al.
HEPATOLOGY (2011)
Effects of Hepatitis B Virus Infection on the Interferon Response in Immunodeficient Human Hepatocyte Chimeric Mice
Masataka Tsuge et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C
Kazuaki Chayama et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
High-resolution characterization of a hepatocellular carcinoma genome
Yasushi Totoki et al.
NATURE GENETICS (2011)
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma
Meng Li et al.
NATURE GENETICS (2011)
Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers
Daiki Miki et al.
NATURE GENETICS (2011)
Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma
Vinod Kumar et al.
NATURE GENETICS (2011)
Hepatitis C Virus Infection Suppresses the Interferon Response in the Liver of the Human Hepatocyte Chimeric Mouse
Masataka Tsuge et al.
PLOS ONE (2011)
ITPA Polymorphism Affects Ribavirin-Induced Anemia and Outcomes of Therapy-A Genome-Wide Study of Japanese HCV Virus Patients
Hidenori Ochi et al.
GASTROENTEROLOGY (2010)
Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
Kazuaki Chayama et al.
HEPATOLOGY RESEARCH (2010)
Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)
Shigeki Arii et al.
HEPATOLOGY RESEARCH (2010)
The Genotypes of IL-1 beta and MMP-3 are Associated with the Prognosis of HCV-related Hepatocellular Carcinoma
Kinya Okamoto et al.
INTERNAL MEDICINE (2010)
Hypersensitivity Reactions to Transcatheter Chemoembolization with Cisplatin and Lipiodol Suspension for Unresectable Hepatocellular Carcinoma
Tomokazu Kawaoka et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C
Jacques Fellay et al.
NATURE (2010)
Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers
Hongxing Zhang et al.
NATURE GENETICS (2010)
Hepatocellular carcinoma: a global view
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Genomewide Association Studies and Assessment of the Risk of Disease
Teri A. Manolio
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A Polymorphism in MAPKAPK3 Affects Response to Interferon Therapy for Chronic Hepatitis C
Hironobu Tsukada et al.
GASTROENTEROLOGY (2009)
Differential MicroRNA Expression Between Hepatitis B and Hepatitis C Leading Disease Progression to Hepatocellular Carcinoma
Shunsuke Ura et al.
HEPATOLOGY (2009)
Diagnosis, Management, and Treatment of Hepatitis C: An Update
Marc G. Ghany et al.
HEPATOLOGY (2009)
Hepatocellular carcinoma in the Asia pacific region
Man-Fung Yuen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Hepatobiliary Cancers
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
Polymorphism of OAS-1 determines liver fibrosis progression in hepatitis C by reduced ability to inhibit viral replication
Chang-Zheng Li et al.
LIVER INTERNATIONAL (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians
Yoichiro Kamatani et al.
NATURE GENETICS (2009)
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genomic and personalized medicine: foundations and applications
Geoffrey S. Ginsburg et al.
TRANSLATIONAL RESEARCH (2009)
Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan population
Sayeh Ezzikouri et al.
ARCHIVES OF MEDICAL RESEARCH (2008)
Risk factors for hepatocellular carcinoma in a Japanese population: A nested case-control study
Waka Ohishi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Interaction between interleukin-1β-31T/C gene polymorphism and drinking and smoking habits on the risk of hepatocellular carcinoma among Japanese
Tatsuhiko Sakamoto et al.
CANCER LETTERS (2008)
UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers
Sun-Young Kong et al.
CANCER SCIENCE (2008)
Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy
Kazuma Kiyotani et al.
CANCER SCIENCE (2008)
MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
Young Joon Yoon et al.
CARCINOGENESIS (2008)
Molecular Mechanisms of Hepatocellular Carcinoma
Rajagopal N. Aravalli et al.
HEPATOLOGY (2008)
A HapMap harvest of insights into the genetics of common disease
Teri A. Manolio et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma
Daiki Miki et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma
Hwai-I Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Genetic polymorphism in the manganese superoxide dismutase gene is associated with an increased risk for hepatocellular carcinoma in HCV-infected Moroccan patients
Sayeh Ezzikouri et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2008)
Manganese superoxide dismutase dimorphism and iron overload, hepatocellular carcinoma, and death in hepatitis C virus-infected patients
Pierre Nahon et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels
Norio Akuta et al.
JOURNAL OF HEPATOLOGY (2007)
Polymorphisms of interleukin-1β in Japanese patients with hepatitis B virus infection
Kiyoshi Migita et al.
JOURNAL OF HEPATOLOGY (2007)
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial
Gregory T. Everson et al.
HEPATOLOGY (2006)
MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C
Narayan Dharel et al.
CLINICAL CANCER RESEARCH (2006)
Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions
Shuen-Lu Hung et al.
PHARMACOGENETICS AND GENOMICS (2006)
American Gastroenterological Association technical review on the management of hepatitis C
JL Dienstag et al.
GASTROENTEROLOGY (2006)
Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma
CC Chen et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2005)
A haplotype map of the human genome
D Altshuler et al.
NATURE (2005)
FAS promoter polymorphisms correlate with activity grade in hepatitis C patients
D Mcllroy et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients
M Romero-Gómez et al.
GASTROENTEROLOGY (2005)
UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in Japanese patients with hepatitis C virus infection
Y Wang et al.
CLINICAL CANCER RESEARCH (2004)
Variation of gene-based SNPs and linkage disequilibrium patterns in the human genome
T Tsunoda et al.
HUMAN MOLECULAR GENETICS (2004)
Hepatocellular carcinoma: Recent trends in Japan
K Kiyosawa et al.
GASTROENTEROLOGY (2004)
Impact of aging on the development of hepatocellular carcinoma in patients with hepatitis C virus infection in Japan
W Ohishi et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
Impact of interleukin-1β genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan
Y Tanaka et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid
M Jinushi et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Interieukin-1 beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection
Y Wang et al.
HEPATOLOGY (2003)
Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction
K Ozaki et al.
NATURE GENETICS (2002)
Combined Intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches
M Sakon et al.
CANCER (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
分享论文
